SMTL ID : 4e20.1

Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 0MY: N-[4-(3-amino-1H-indazol-5-yl)phenyl]-3-chlorobenzenesulfonamide(Non-covalent)

0MY.1: 17 residues within 4Å: Chain A: L.16, G.17, E.18, G.19, G.22, K.23, V.24, A.41, K.43, E.92, Y.93, V.94, R.140, N.141, L.143, G.153, D.154 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.16, A:V.24, A:V.24, A:A.41, A:L.143, A:L.143, A:D.154 Hydrogen bonds: A:E.18, A:E.92, A:V.94, A:V.94, A:R.140, A:R.140 Water bridges: A:R.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Argiriadi, M.A. et al., Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor. Bmc Struct.Biol. (2012)

Release Date

2012-10-03

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2